Skip to main content
. 2021 Apr 1;16(1):9–19. doi: 10.31616/asj.2020.0557

Table 2.

Various ATT regimes followed by the respondents (n=17)

ATT regime No. of respondents
2 HRZE+10 HR 5
2 HRZE+10 HRE 4
2 HRZE+7 HRE+9 HR 1
3 HRZE+3 HRE+6 HR 2
4 HRZE+5 HRE 1
4 HRZE+14 HRE 2

ATT, anti-tubercular treatment; H, isoniazid; R, rifampicin; Z, pyrazinamide; E, ethambutol.